| P2093 | author name string | Alexandre Morrot | |
| | Daniel Ferreira Feijó | |
| | Dirlei Nico | |
| | Julio Scharfstein | |
| | Clarisa Beatriz Palatnik-de-Sousa | |
| | Marcos Palatnik | |
| | Naiara Maran | |
| P2860 | cites work | Bradykinin B2 Receptors of dendritic cells, acting as sensors of kinins proteolytically released by Trypanosoma cruzi, are critical for the development of protective type-1 responses | Q27319499 |
| | Crystal structures of T. vivax nucleoside hydrolase in complex with new potent and specific inhibitors | Q27654085 |
| | Divalent cation transport and susceptibility to infectious and autoimmune disease: continuation of the Ity/Lsh/Bcg/Nramp1/Slc11a1 gene story | Q28203008 |
| | Adaptive immunity against Leishmania nucleoside hydrolase maps its c-terminal domain as the target of the CD4+ T cell-driven protective response | Q28476049 |
| | Regulation of Leishmania populations within the host. II. genetic control of acute susceptibility of mice to Leishmania donovani infection | Q28594805 |
| | Cytokine responses to novel antigens in a peri-urban population in Brazil exposed to Leishmania infantum chagasi. | Q30416865 |
| | Genetic admixture in Brazilians exposed to infection with Leishmania chagasi. | Q30438885 |
| | Enhanced hematopoietic activity accompanies parasite expansion in the spleen and bone marrow of mice infected with Leishmania donovani | Q34003789 |
| | Immunodominant antigens of Leishmania chagasi associated with protection against human visceral leishmaniasis | Q34314499 |
| | Balancing immunity and pathology in visceral leishmaniasis | Q34587432 |
| | Vaccines for leishmaniasis in the fore coming 25 years. | Q34754538 |
| | Anti-nociceptive effect of kinin B₁ and B₂ receptor antagonists on peripheral neuropathy induced by paclitaxel in mice | Q35287537 |
| | One Health: the global challenge of epidemic and endemic leishmaniasis | Q35544183 |
| | Immunopathogenesis of infection with the visceralizing Leishmania species | Q36083616 |
| | Immunoglobulin G subclass distribution in canine leishmaniosis: a review and analysis of pitfalls in interpretation | Q36805420 |
| | Genetic and functional evaluation of the role of DLL1 in susceptibility to visceral leishmaniasis in India | Q36837346 |
| | Canine leishmaniosis - new concepts and insights on an expanding zoonosis: part one. | Q37177903 |
| | FML vaccine against canine visceral leishmaniasis: from second-generation to synthetic vaccine | Q37229935 |
| | Kinin danger signals proteolytically released by gingipain induce Fimbriae-specific IFN-gamma- and IL-17-producing T cells in mice infected intramucosally with Porphyromonas gingivalis. | Q37332549 |
| | The role of host genetics in leishmaniasis | Q37555703 |
| | Correlates of protection induced by vaccination | Q37750121 |
| | Defective CCR7 expression on dendritic cells contributes to the development of visceral leishmaniasis | Q38883160 |
| | Towards multilocus sequence typing of the Leishmania donovani complex: resolving genotypes and haplotypes for five polymorphic metabolic enzymes (ASAT, GPI, NH1, NH2, PGD). | Q39227296 |
| | IgG subclass profile of serum antibodies to Leishmania chagasi in naturally infected and vaccinated dogs | Q39880059 |
| | Interleukin 10 gene polymorphisms and development of post kala-azar dermal leishmaniasis in a selected sudanese population | Q41830302 |
| | Immunotherapy with the saponin enriched-Leishmune vaccine versus immunochemotherapy in dogs with natural canine visceral leishmaniasis. | Q43267738 |
| | Cooperative activation of TLR2 and bradykinin B2 receptor is required for induction of type 1 immunity in a mouse model of subcutaneous infection by Trypanosoma cruzi. | Q43467779 |
| | Nucleoside hydrolase from Leishmania (L.) donovani is an antigen diagnostic for visceral leishmaniasis. | Q45982388 |
| | Protective vaccination against experimental canine visceral leishmaniasis using a combination of DNA and protein immunization with cysteine proteinases type I and II of L. infantum. | Q46480653 |
| | Interplay between parasite cysteine proteases and the host kinin system modulates microvascular leakage and macrophage infection by promastigotes of the Leishmania donovani complex | Q46734738 |
| | Cutting edge: bradykinin induces IL-12 production by dendritic cells: a danger signal that drives Th1 polarization. | Q47898009 |
| | Effects of the bradykinin B1 receptor antagonist des-Arg9[Leu8]bradykinin and genetic disruption of the B2 receptor on nociception in rats and mice. | Q52526041 |
| | Vaccines for canine leishmaniasis | Q56769198 |
| | Polymorphism of Slc11a1 (Nramp1) Gene and Canine Leishmaniasis in a Case-Control Study | Q61415811 |
| | Immunohistological features of visceral leishmaniasis in BALB/c mice | Q63408513 |
| | Regulation of Leishmania populations within the host. I. the variable course of Leishmania donovani infections in mice | Q67063595 |
| | Saponins, IL12 and BCG adjuvant in the FML-vaccine formulation against murine visceral leishmaniasis | Q78550077 |
| P921 | main subject | visceral leishmaniasis | Q2046113 |
| P304 | page(s) | 261 | |
| P577 | publication date | 2012-11-14 | |
| P1433 | published in | Parasites and Vectors | Q7135941 |
| P1476 | title | Resistance to visceral leishmaniasis is severely compromised in mice deficient of bradykinin B2-receptors | |
| P478 | volume | 5 | |